English | 繁體

Search in the results

UM

Browse/Search Results:  1-7 of 7 Help

Selected(0)Clear Items/Page:    Sort:
Obstacles and opportunities in Chinese pharmaceutical innovation Journal article
Ni J., Zhao J., Ung C.O.L., Hu Y., Hu H., Wang Y.. Obstacles and opportunities in Chinese pharmaceutical innovation[J]. Globalization and Health, 2017, 13(1), 21.
Authors:  Ni J.;  Zhao J.;  Ung C.O.L.;  Hu Y.;  Hu H.; et al.
Favorite | TC[WOS]:29 TC[Scopus]:27 | Submit date：2018/11/06
China  Global Network  Innovation  Obstacles  Opportunities  Pharmaceutical Industry  
Innovation Value Chain of Chinese Pharmaceuticals Book
Yitao Wang, Yuanjia Hu, Albert Wai-Kit Chan. Innovation Value Chain of Chinese Pharmaceuticals[M]. 141-07 20th Avenue World Plaza, Suite 604 Whitestone, NY 11357:United States-China Intellectual Property Institute Inc., 2017, 286.
Authors:  Yitao Wang;  Yuanjia Hu;  Albert Wai-Kit Chan
Favorite |  | Submit date：2019/01/14
China  Pharmaceutical Industry  Obstacles  Opportunities  Global Network  Innovation  
Pharmaceutical innovation network: Global patterns and the role of China Book chapter
出自: Innovation Value Chain of Chinese Pharmaceuticals, Whitestone, New York:United States-China Intellectual Property Institute Inc., 2017, 页码:259-281
Authors:  Pengpeng Li;  Huiheng Lin;  Yuanjia Hu
Favorite |  | Submit date：2019/01/15
Pharmaceutical Innovation  Drug Patents  Network Analysis  
Evolving patterns in a collaboration network of global R&D on monoclonal antibodies Journal article
Kong, Xiangjun, Wan, Jian-bo, Hu, Hao, Su, Shibing, Hu, Yuanjia. Evolving patterns in a collaboration network of global R&D on monoclonal antibodies[J]. MABS, 2017, 9(7), 1041-1051.
Authors:  Kong, Xiangjun;  Wan, Jian-bo;  Hu, Hao;  Su, Shibing;  Hu, Yuanjia
Favorite | TC[WOS]:3 TC[Scopus]:7  IF:5.6/5.8 | Submit date：2020/05/08
Pharmaceutical Companies  Collaboration Network  Dedicated Biotechnology Firms  Inter-organizational Relationship  Mergers And Acquisitions  Monoclonal Antibodies  Network Evolution  r&d  Technological Innovation  
Evolving patterns in a collaboration network of global R&D on monoclonal antibodies Journal article
Kong, Xiangjun, Wan, Jian-bo, Hu, Hao, Su, Shibing, Hu, Yuanjia. Evolving patterns in a collaboration network of global R&D on monoclonal antibodies[J]. MABS, 2017, 9(7), 1041-1051.
Authors:  Kong, Xiangjun;  Wan, Jian-bo;  Hu, Hao;  Su, Shibing;  Hu, Yuanjia
Favorite | TC[WOS]:3 TC[Scopus]:7  IF:5.6/5.8 | Submit date：2018/10/30
Collaboration Network  Dedicated Biotechnology Firms  Inter-organizational Relationship  Mergers And Acquisitions  Monoclonal Antibodies  Network Evolution  r&d  Pharmaceutical Companies  Technological Innovation  
Biopharmaceutical innovation system in China: System evolution and policy transitions (pre-1990s-2010s) Journal article
Hu H., Chung C.-C.. Biopharmaceutical innovation system in China: System evolution and policy transitions (pre-1990s-2010s)[J]. International Journal of Health Policy and Management, 2015, 4(12), 823-829.
Authors:  Hu H.;  Chung C.-C.
Favorite | TC[WOS]:6 TC[Scopus]:8 | Submit date：2018/12/28
Biopharmaceutical  Biotechnology  China  Pharmaceutical Industry  Sectoral Innovation System (Sis)  
基于网络能力视角的制药企业研发创新演进 Journal article
Lai, Y.F., Hu, H.. 基于网络能力视角的制药企业研发创新演进[J]. 科技管理研究, 2012, 9-12.
Authors:  Lai, Y.F.;  Hu, H.
Favorite |  | Submit date：2022/07/27
network competence  pharmaceutical innovation  technological capability